Investigational triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. Studied for weight management, appetite regulation, metabolism, and glucose control. Research use only. Not FDA approved for human consumption or medical use.
Investigational triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. Studied for weight management, appetite regulation, metabolism, and glucose control. Research use only. Not FDA approved for human consumption or medical use.
| Size | 10mg, 20mg, 30mg |
|---|
Reviews
There are no reviews yet.